Diagnosing fraudulent baseline data in clinical trials
The first table in many articles reporting results of a randomized clinical trial compares baseline factors across arms. Results that appear inconsistent with chance trigger suspicion, and in one case, accusation and confirmation of data falsification. We confirm theoretically results of simulation...
Main Authors: | Michael A. Proschan, Pamela A. Shaw, Vance Berger |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7527254/?tool=EBI |
Similar Items
-
Diagnosing fraudulent baseline data in clinical trials.
by: Michael A Proschan, et al.
Published: (2020-01-01) -
OFFENCE OF FRAUDULENT MANAGEMENT
by: ION CRISTINEL RUJAN
Published: (2014-12-01) -
PROBLEMS IDENTIFYING FRAUDULENT BANKRUPTCY IN RUSSIA
by: A. A. Abdullaev
Published: (2014-11-01) -
Non-financial Indicators of Fraudulent Bankruptcy
by: M. A. Gorodilov, et al.
Published: (2019-06-01) -
Are there significant mean differences in the financial ratios between fraudulent and non-fraudulent companies in Vietnam?
by: Đinh Ngọc Tú, et al.
Published: (2020-06-01)